Buy Fractional Shares of Top US Stocks. Start Investing with just $1!
+91
US Biotechnology Stocks
as onThis industry covers companies focused on drug discovery and development using biological processes, including Amgen, Gilead Sciences, and Moderna. Stock performance is often tied to clinical trial results and FDA approval decisions, making biotech a higher-risk, higher-reward corner of healthcare investing driven by scientific breakthroughs. Cash-rich pipelines and pharma M&A add further catalysts.
Name | LTP | Change % | Volume | Market Cap (Mn)  | PE Ratio | Industry PE | 52W High | 1M Returns | 3M Returns | 1 Yr Returns | 3 Yr Returns | 5 Yr Returns | ROE | ROCE |
|---|
$547.00 | 0.83% | 7,72,346 | $138,684 | 31.55 | 58.02 | $560.25 | 8.64% | 12.84% | 31.17% | 41.80% | 183.64% | 22.97% | 20.80% | |
$60.91 | -3.44% | 46,56,504 | $131,238 | 14.38 | 58.02 | $67.30 | 15.24% | 2.71% | 13.04% | 96.28% | 76.13% | 16.74% | 12.01% | |
$254.30 | 5.32% | 1,52,83,832 | $101,524 | - | 58.02 | $227.46 | 25.19% | 352.18% | 979.35% | 252.84% | 7.30% | -29.19% | -28.30% | |
$904.42 | 0.17% | 6,32,112 | $91,917 | 19.64 | 58.02 | $859.34 | 24.51% | 17.65% | 40.40% | 8.65% | 47.89% | 14.93% | 13.08% | |
$928.67 | 3.79% | 3,39,162 | $58,400 | 38.99 | 58.02 | $1,072.75 | 1.68% | 6.93% | 11.57% | 88.36% | 189.38% | 25.18% | 17.65% | |
$407.16 | 5.14% | 8,27,464 | $44,701 | 65.60 | 57.72 | $385.22 | 12.52% | 24.35% | 26.69% | 121.28% | 121.28% | 7.51% | 8.69% | |
$192.41 | 8.31% | 39,57,530 | $41,617 | - | 58.02 | $224.31 | -7.40% | -2.28% | 224.25% | 793.28% | 470.96% | -59.94% | -54.86% | |
$53.61 | 1.66% | 74,42,704 | $33,458 | 26.24 | 57.72 | $40.17 | 39.33% | 83.19% | 83.67% | 85.83% | 15.40% | 17.62% | 16.07% | |
$67.30 | -0.40% | 33,84,514 | $29,968 | 32.37 | 58.02 | $64.38 | 18.84% | 16.56% | 66.51% | 142.27% | 70.30% | 20.14% | 9.05% | |
$38.92 | 6.27% | 96,93,916 | $28,111 | - | 57.72 | $42.50 | 8.76% | 12.50% | 92.37% | 337.76% | 402.80% | -13.80% | -15.76% | |
$114.55 | 5.32% | 27,14,936 | $25,129 | - | 57.72 | $212.75 | 10.36% | 15.77% | -38.71% | 380.48% | 242.65% | -192.35% | -64.91% | |
$119.67 | 1.40% | 9,71,674 | $24,392 | 15.85 | 57.72 | $132.60 | 4.88% | -0.11% | 13.21% | 119.29% | 76.34% | 30.48% | 34.23% | |
$87.53 | 1.94% | 6,05,375 | $21,988 | - | 57.72 | $124.00 | -10.31% | -5.08% | -15.37% | -12.22% | -59.60% | -6.01% | -5.27% | |
$155.98 | -0.43% | 21,48,574 | $20,892 | 39.98 | 58.02 | $495.55 | -29.07% | -31.75% | -64.11% | -6.68% | -16.70% | 107.73% | 14.28% | |
$69.59 | 1.27% | 14,93,548 | $16,980 | 17.17 | 58.02 | $61.66 | 18.34% | 22.63% | 72.37% | 233.90% | 259.43% | 36.46% | 35.70% | |
$256.82 | 1.33% | 7,15,892 | $16,020 | 19.00 | 58.02 | $282.15 | 12.52% | 5.27% | 29.87% | 172.02% | 59.83% | - | -73.51% | |
$234.68 | 3.24% | 5,99,007 | $15,064 | 16.76 | 58.02 | $266.38 | -0.62% | -10.31% | 71.03% | 76.73% | 73.76% | -8.79% | -4.45% | |
$74.28 | 0.01% | 21,67,996 | $14,470 | - | 58.02 | $93.42 | 12.34% | -9.40% | 18.54% | 166.42% | 39.07% | - | -74.98% | |
$16.33 | 15.09% | 51,06,503 | $13,061 | - | 57.72 | $29.23 | -5.48% | 20.66% | -9.62% | 649.13% | 189.56% | -292.77% | -286.88% | |
$103.67 | -15.69% | 57,00,392 | $11,766 | 30.80 | 58.02 | $119.21 | -4.27% | 24.03% | 51.79% | 194.02% | 154.65% | 91.50% | 25.20% | |
$72.79 | 0.18% | 16,49,694 | $11,432 | 62.37 | 57.72 | $72.69 | 0.28% | 1.11% | 21.44% | 24.03% | -41.45% | 3.59% | 4.12% | |
$131.76 | 2.84% | 6,13,450 | $11,248 | - | 57.72 | $130.05 | 20.06% | 24.89% | 119.99% | 814.97% | 102.89% | -30.41% | -31.75% | |
$56.02 | -0.18% | 22,69,794 | $10,851 | 174.69 | 57.72 | $70.98 | -2.61% | -6.51% | 6.10% | -26.50% | -33.25% | 5.88% | 6.28% | |
$63.84 | 3.10% | 15,84,162 | $10,106 | - | 58.02 | $90.75 | -13.55% | 14.13% | 58.34% | 32.31% | 152.24% | -25.29% | -28.46% | |
$103.87 | 7.54% | 9,95,812 | $9,865 | - | 57.72 | $110.18 | 12.10% | -0.14% | 354.59% | 616.37% | 616.37% | -42.01% | -33.52% |
Total 565 records
*The scrips mentioned above are just for research purpose and not recommendations. Please do your own due diligence before investing.
Invest in US Stocks with Dhan
Start building a global portfolio from just $1.
4.5 ratings
4.0 ratings
